Sanofi-Aventis enters blood test market

Sanofi-Aventis, makers of Lantus, an analog insulin, and Apidra,  is looking to become a “healthcare” company, not just a drugmaker. The move takes the group into the world of medical devices and is part of a strategy by Chief Executive Chris Viehbacher to diversify Sanofi, reducing its traditional reliance on branded prescription drugs.French drugmaker Sanofi-Aventis is now venturing into the world of blood sugar testing, according to a recent Reuters article. The company agreed to develop monitoring systems with privately held U.S. firm AgaMatrix. The company expects to co-develop a glucose monitoring system with AgaMatrix and begin selling the monitor in the second half of this year. AgaMatrix already makes a line of blood glucose monitoring products. To see the likely outcome — due to launch in 2011 — go to

Desang Diabetes Magazine is our free-to-receive digital journal (see below). We cover diabetes news, diabetes management equipment (diabetes ‘kit’ such as insulin pumps and continuous glucose monitoring equipment) and news about food suitable for a diabetic diet including a regular Making Carbs Count column. We just need your email address to subscribe you (it really is free, and you can easily unsubscribe should you wish to).

Sign me up!
Open publication
Buy a Desang kitbag

See our range of kitbags